200 related articles for article (PubMed ID: 18441198)
1. Inhibitory effect of D1-like and D3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells.
Li Z; Yu C; Han Y; Ren H; Shi W; Fu C; He D; Huang L; Yang C; Wang X; Zhou L; Asico LD; Zeng C; Jose PA
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2761-8. PubMed ID: 18441198
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of D1-like dopamine receptors on neuropeptide Y-induced proliferation in vascular smooth muscle cells.
Zhou Y; Shi W; Luo H; Yue R; Wang Z; Wang W; Liu L; Wang WE; Wang H; Zeng C
Hypertens Res; 2015 Dec; 38(12):807-12. PubMed ID: 26178154
[TBL] [Abstract][Full Text] [Related]
3. D1-like receptors inhibit insulin-induced vascular smooth muscle cell proliferation via down-regulation of insulin receptor expression.
Zeng C; Han Y; Huang H; Yu C; Ren H; Shi W; He D; Huang L; Yang C; Wang X; Zhou L; Jose PA
J Hypertens; 2009 May; 27(5):1033-41. PubMed ID: 19293728
[TBL] [Abstract][Full Text] [Related]
4. Dopamine d(1)-like receptors suppress proliferation of vascular smooth muscle cell induced by insulin-like growth factor-1.
Kou X; Han Y; Yang D; Liu Y; Fu J; Zheng S; He D; Zhou L; Zeng C
Clin Exp Hypertens; 2014; 36(3):140-7. PubMed ID: 23713966
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D1 receptor augmentation of D3 receptor action in rat aortic or mesenteric vascular smooth muscles.
Zeng C; Wang D; Yang Z; Wang Z; Asico LD; Wilcox CS; Eisner GM; Welch WJ; Felder RA; Jose PA
Hypertension; 2004 Mar; 43(3):673-9. PubMed ID: 14769810
[TBL] [Abstract][Full Text] [Related]
6. Aberrant D1 and D3 dopamine receptor transregulation in hypertension.
Zeng C; Wang D; Asico LD; Welch WJ; Wilcox CS; Hopfer U; Eisner GM; Felder RA; Jose PA
Hypertension; 2004 Mar; 43(3):654-60. PubMed ID: 14732731
[TBL] [Abstract][Full Text] [Related]
7. Dopamine acting at D1-like, D2-like and α1-adrenergic receptors differentially modulates theta and gamma oscillatory activity in primary motor cortex.
Özkan M; Johnson NW; Sehirli US; Woodhall GL; Stanford IM
PLoS One; 2017; 12(7):e0181633. PubMed ID: 28732063
[TBL] [Abstract][Full Text] [Related]
8. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
[TBL] [Abstract][Full Text] [Related]
9. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
Graham DL; Hoppenot R; Hendryx A; Self DW
Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
[TBL] [Abstract][Full Text] [Related]
10. Renal vasodilatation by dopexamine and fenoldopam due to alpha 1-adrenoceptor blockade.
Martin SW; Broadley KJ
Br J Pharmacol; 1995 May; 115(2):349-55. PubMed ID: 7670737
[TBL] [Abstract][Full Text] [Related]
11. Activation of the D4 dopamine receptor attenuates proliferation and migration of vascular smooth muscle cells through downregulation of AT1a receptor expression.
Yu C; Chen J; Guan W; Han Y; Wang WE; Wang X; Wang H; Jose PA; Zeng C
Hypertens Res; 2015 Sep; 38(9):588-96. PubMed ID: 25832920
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of D3 dopamine receptor on migration of vascular smooth muscle cells induced by synergistic effect of angiotensin II and aldosterone.
Li Y; Wang N; Chen C; He D; Yang J; Zeng C
Clin Exp Hypertens; 2015; 37(4):288-93. PubMed ID: 25496286
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of the D(3) dopamine receptor on insulin receptor expression and function in vascular smooth muscle cells.
Huang H; Han Y; Wang X; Chen C; Yu C; He D; Wang H; Zhou L; Asico LD; Jose PA; Zeng C
Am J Hypertens; 2011 Jun; 24(6):654-60. PubMed ID: 21415841
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of D3 dopamine receptors on neuropeptide Y‑induced migration in vascular smooth muscle cells.
Xia XW; Zhou YQ; Luo H; Zeng C
Mol Med Rep; 2017 Oct; 16(4):5606-5610. PubMed ID: 28849020
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D₄ receptors inhibit proliferation and migration of vascular smooth muscle cells induced by insulin via down-regulation of insulin receptor expression.
Yu C; Wang Z; Han Y; Liu Y; Wang WE; Chen C; Wang H; Jose PA; Zeng C
Cardiovasc Diabetol; 2014 Jun; 13():97. PubMed ID: 24888351
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-β peptides activate α1-adrenergic cardiovascular receptors.
Haase N; Herse F; Spallek B; Haase H; Morano I; Qadri F; Szijártó IA; Rohm I; Yilmaz A; Warrington JP; Ryan MJ; Gollasch M; Müller DN; Dechend R; Wallukat G
Hypertension; 2013 Nov; 62(5):966-72. PubMed ID: 24001898
[TBL] [Abstract][Full Text] [Related]
17. Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats.
Zeng C; Luo Y; Asico LD; Hopfer U; Eisner GM; Felder RA; Jose PA
Hypertension; 2003 Oct; 42(4):787-92. PubMed ID: 12900438
[TBL] [Abstract][Full Text] [Related]
18. Biphasic effects of D3-receptor agonists, 7-OH-DPAT and PD128907, on the D1-receptor agonist-induced hyperactivity in mice.
Mori T; Murase K; Tanaka J; Ichimaru Y
Jpn J Pharmacol; 1997 Mar; 73(3):251-4. PubMed ID: 9127821
[TBL] [Abstract][Full Text] [Related]
19. Peripheral relaxant activity of apomorphine and of a D1 selective receptor agonist on human corpus cavernosum strips.
d'Emmanuele di Villa Bianca R; Sorrentino R; Roviezzo F; Imbimbo C; Palmieri A; De Dominicis G; Montorsi F; Cirino G; Mirone V
Int J Impot Res; 2005; 17(2):127-33. PubMed ID: 15549138
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex.
Pan WH; Yang SY; Lin SK
Synapse; 2004 Jul; 53(1):44-52. PubMed ID: 15150740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
